These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7693510)

  • 1. Reversible inactivation of endothelial nitric oxide synthase by NG-nitro-L-arginine.
    Mayer B; Schmid M; Klatt P; Schmidt K
    FEBS Lett; 1993 Oct; 333(1-2):203-6. PubMed ID: 7693510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
    Schmidt K; Klatt P; Mayer B
    Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
    Joly GA; Ayres M; Chelly F; Kilbourn RG
    Biochem Biophys Res Commun; 1994 Feb; 199(1):147-54. PubMed ID: 7510104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
    Reif DW; McCreedy SA
    Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation.
    Klatt P; Schmidt K; Brunner F; Mayer B
    J Biol Chem; 1994 Jan; 269(3):1674-80. PubMed ID: 7507482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonic regulation of mouse ileal ion transport by nitric oxide.
    Rao RK; Riviere PJ; Pascaud X; Junien JL; Porreca F
    J Pharmacol Exp Ther; 1994 May; 269(2):626-31. PubMed ID: 7514221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
    Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
    Bogle RG; Moncada S; Pearson JD; Mann GE
    Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
    McCall TB; Feelisch M; Palmer RM; Moncada S
    Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells.
    Schmidt K; Klatt P; Mayer B
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):313-6. PubMed ID: 7519006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.
    Olken NM; Marletta MA
    Biochemistry; 1993 Sep; 32(37):9677-85. PubMed ID: 7690590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase.
    Heinzel B; John M; Klatt P; Böhme E; Mayer B
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):627-30. PubMed ID: 1371384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characteristics of nitric oxide synthase from rat brain.
    Knowles RG; Palacios M; Palmer RM; Moncada S
    Biochem J; 1990 Jul; 269(1):207-10. PubMed ID: 1695842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
    J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
    Shimizu S; Nomoto M; Yamamoto T; Momose K
    Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
    Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
    Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis.
    Mulligan MS; Moncada S; Ward PA
    Br J Pharmacol; 1992 Dec; 107(4):1159-62. PubMed ID: 1281719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neuronal amino acid transporters: uptake of nitric oxide synthase inhibitors and implication for their biological effects.
    Schmidt K; List BM; Klatt P; Mayer B
    J Neurochem; 1995 Apr; 64(4):1469-75. PubMed ID: 7534332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a calmodulin-dependent nitric oxide synthase from GH3 pituitary cells.
    Wolff DJ; Datto GA
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):201-6. PubMed ID: 1379040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.